Document:

NEITHER THIS WARRANT NOR THE SHARES
OF COMMON STOCK UNDERLYING THIS WARRANT OF BLONDER TONGUE LABORATORIES, INC. (THE “COMPANY”) HAVE BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD,
ASSIGNED OR TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE
SECURITIES LAW AND SUCH SALE OR TRANSFER IS MADE IN ACCORDANCE WITH SUCH REGISTRATION STATEMENT AND ANY OTHER APPLICABLE STATE
SECURITIES LAW OR (ii) THE COMPANY RECEIVES A WRITTEN OPINION OF COUNSEL TO THE COMPANY OR OTHER COUNSEL TO THE HOLDER OF SUCH
WARRANT (OR SUCH UNDERLYING SHARES OF COMMON STOCK), PROVIDED SUCH OTHER COUNSEL IS REASONABLY SATISFACTORY TO THE COMPANY, THAT
SUCH PLEDGE, SALE, ASSIGNMENT OR TRANSFER MAY BE MADE WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE
SECURITIES LAWS. 

 

Date: As of May 23, 2012

 

WARRANT TO PURCHASE 100,000 SHARES OF
COMMON STOCK

OF

BLONDER
TONGUE LABORATORIES, INC.

 

THIS CERTIFIES that,
for value received, Adaptive Micro-Ware, Inc., an Indiana corporation (the “Holder”), is entitled to purchase
from Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), One Hundred Thousand (100,000)
(“Warrant Shares”) fully paid, validly issued and non-assessable unregistered shares of common stock of the
Company, $.001 par value per share (the “Common Stock”), subject to adjustment as provided herein, at a purchase
price of $1.09 per share, which is acknowledged to be the market price and fair market value of each share as of the date hereof
(“Exercise Price”).

 

1.          Vesting.
The purchase rights under this Warrant shall vest and be exercisable for the number of shares and during the specific exercise
periods (the “Exercise Periods”) as follows:

 

(i)          33,334
shares commencing on May 23, 2013 and until May 22, 2017;

 

(ii)         33,333
shares commencing on May 23, 2014 and until May 22, 2017; and

 

(iii)        33,333
shares commencing on May 23, 2015 and until May 22, 2017.

 

2.          Exercise
of Warrant. This Warrant may be exercised in whole or in part (but not as to fractional shares and only with respect to properly
vested purchase rights) during the Exercise Periods by the surrender of the Warrant, with the Purchase Agreement attached hereto
as Rider A properly completed and duly executed, at the principal office of the Company at One Jake Brown Road, Old Bridge,
New Jersey 08857, or such other location which shall at that time be the principal office of the Company, and upon payment to the
Company of the Exercise Price multiplied by the number of shares to be purchased upon such exercise. The Exercise Price shall be
paid in immediately available funds to the order of the Company by cashier’s check, certified check or wire transfer. Upon
receipt thereof, the Company shall, as promptly as practicable, execute or cause to be executed and deliver to the Holder a certificate
or certificates as the Holder shall designate representing the number of shares represented by the Holder’s exercise. Unless
and until such time as the Warrant Shares have been registered under the Securities Act of 1933, as amended (“Securities
Act”), certificates representing such Warrant Shares shall bear restrictive legends. The stock certificate or certificates
so delivered shall be in such denominations as may be specified in said notice and shall be registered in the name of the Holder
or in such other name as shall be designated in such notice. This Warrant shall be deemed to have been exercised and such certificate
or certificates shall be deemed to have been issued and the Holder or such other person so designated shall be deemed to have become
a holder of record of such shares for all purposes, as of the date said notice and payment in full is received by the Company.
Unless this Warrant has expired, if this Warrant shall have been exercised only in part, a new Warrant of like tenor and for such
number of shares as the Holder shall direct, representing in the aggregate the right to purchase a number of shares with respect
to which this Warrant shall not have been exercised, shall also be issued to the Holder within such time.

 

3.          Transfer/Warrant
Shares Legend. This Warrant and the rights hereunder shall be non-transferrable. Each certificate representing Warrant Shares
shall contain a legend in substantially the following form:

 

THE SHARES
OF STOCK REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE OR OTHER
SECURITIES LAWS. UNLESS AN EXEMPTION IS AVAILABLE OR THE SHARES ARE REGISTERED UNDER SAID ACT AND LAWS, THE SHARES MUST BE HELD
INDEFINITELY.

 

4.          Certain
Covenants of the Company. The Company covenants and agrees that all shares which may be issued upon the exercise of this Warrant,
will, upon issuance, be duly and validly issued, fully paid and nonassessable. The Company covenants and agrees that during the
Exercise Periods the Company will at all times have authorized, and reserved for the purpose of issue upon exercise of the purchase
rights evidenced by this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of the rights represented
by this Warrant.

 

5.          Anti-Dilution
Provisions. The number and character of the shares underlying this Warrant shall be subject to adjustment only as provided
in this Section 5. In the event of a stock split, stock dividend, reverse stock split or combination of the Common Stock of the
Company, an equitable adjustment shall be made by the Company in the number of shares for which this Warrant has been issued with
respect thereto, and the Exercise Price which must be paid therefor, provided that no such adjustment shall either (i) diminish
the proportionate interest of the Holder prior to the occurrence of the event or (ii) increase the aggregate Exercise Price to
be paid by the Holder upon exercise of the Warrant in full. In addition, in case at any time and from time to time during the Exercise
Periods, the Company shall be a party to any transaction, including, without limitation, a merger, consolidation, liquidation,
combination, reorganization or recapitalization of the Common Stock (each, a “Transaction”), in which the previously
outstanding common stock of the Company shall be changed into or exchanged for different securities of the Company or common stock
or other securities of another corporation (collectively, “Acquiror Common Stock”) or other property (including
cash) or any combination of the foregoing, then in such event: (i) the Warrant shall become fully exercisable notwithstanding the
date of the event and (ii) as often as such event shall occur, as a condition of the consummation of the Transaction, the Company
or the surviving company, as the case may be, shall make lawful and adequate provision so that the Holder, upon the exercise thereof
at any time on or after the consummation of the Transaction during the Exercise Periods, shall be entitled to receive, and the
Warrant shall thereafter represent the right to receive, in lieu of the common stock issuable upon such conversion prior to such
consummation (determined on a fully vested basis), the securities or other property to which the Holder would have been entitled
upon consummation of the Transaction if the Holder had exercised such Warrant immediately prior thereto. There shall be no preemptive
rights associated with the Warrant or the Warrant Shares issuable thereunder.

 

    	 

    	 

    

 

6.          Change
in Control. In the event of any contemplated transaction which may constitute a change in control of the Company, the vesting
of the Holder’s right to exercise the Warrant shall accelerate and all Holder rights that are not then vested and exercisable
pursuant to Section 1 above shall become vested and exercisable immediately upon the change in control and shall be exercisable
until May 22, 2017. For this purpose, “change in control of the Company” means a change in control of such nature
that it would be required to be reported to the Securities and Exchange Commission (“SEC”) pursuant to Schedule
14A of Regulation 14A or any successor provision under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) (whether or not the Company is then subject to such reporting requirements). A change of control will be deemed
to have occurred if any person, other than persons or entities who on the date hereof are the “beneficial owners” (as
determined pursuant to Sections 13(d) and 14(d) of the Exchange Act), directly or indirectly, of securities of the Company representing
10% or more of the combined voting power of the Company’s then outstanding securities, is or becomes the “beneficial
owner” of 25% or more of the combined voting power of the outstanding securities of the Company or if during two consecutive
year periods, the directors at the beginning of such periods cease for any reason during the two-year period to constitute a majority
of the Board of Directors of the Company.

 

7.          Notice
of Adjustments. Whenever any of the number of shares of Common Stock purchasable or Exercise Price to be paid under the terms
of this Warrant shall be adjusted pursuant to Section 5 hereof, the Company shall notify the Holder at the Holder’s last
address known to the Company.

 

8.          Fractional
Shares. No fractional shares of the Company’s Common Stock will be issued in connection with any purchase hereunder but
in lieu of such fractional shares, the Company shall make a cash refund therefor equal in amount to the product of the applicable
fraction multiplied by the Exercise Price.

 

9.          Registration
Rights.

 

(a)          Piggyback
Rights. If the Company proposes to register any of its Common Stock under the Securities Act in connection with the
public offering of such securities solely for cash (other than in (i) a registration
relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or
similar plan; (ii) a registration relating to a transaction under Rule 145 promulgated by the SEC under the Securities Act;
(iii) a registration on any form that does not include substantially the same information as would be required to be included
in a registration statement covering the sale of the Registrable Securities (as defined below); (iv) a registration in
connection with an offering pursuant to which the Company is seeking to receive less than $5,000,000; or (v) a registration
in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also
being registered), the Company shall, at such time, promptly give the Holder notice of such registration. Upon the
request of Holder, given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the
provisions of Subsection 9(b), cause to be registered (x) all of the Common Stock issuable or issued upon exercise of
this Warrant and (y) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other
security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the
shares referenced in clause (x) above (collectively, “Registrable Securities”) that the Holder has
requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration
initiated by it under this Section 9 before the effective date of such registration, whether or not the Holder has
elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses (as defined
below)) of such withdrawn registration shall be borne by the Company in accordance with Subsection 9(d). 

 

(b)          Underwriting
Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant
to Subsection 9(a), the Company shall not be required to include any of the Holder’s Registrable Securities in such
underwriting unless the Holder accepts the terms of the underwriting as agreed upon between the Company and its underwriters, and
then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering
by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in
such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable
discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering
only that number of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion
determine will not jeopardize the success of the offering.

 

(c)          Furnish
Information. It shall be a condition precedent to the obligations of the Company to take any action
pursuant to this Section 9 with respect to the Registrable Securities of the Holder that the Holder shall furnish to the
Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such
securities as is reasonably required to effect the registration of the Holder’s Registrable Securities. 

 

(d)          Expenses
of Registration. All expenses (other than underwriting discounts, selling commissions, and stock
transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder (collectively,
“Selling Expenses”)) incurred in connection with registrations, filings, or qualifications pursuant to Section
9, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements
of counsel for the Company shall be borne and paid by the Company. 

 

(e)          Delay
of Registration. Holder shall not have any right to obtain or seek an injunction restraining or
otherwise delaying any registration pursuant to this Warrant as the result of any controversy that might arise with respect to
the interpretation or implementation of this Section 9.

 

(f)          Indemnification.
If any Registrable Securities are included in a registration statement under this Section 9: 

 

(i) To the extent
permitted by law, the Holder will indemnify and hold harmless the Company, and each of its directors, each of its officers who
has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act,
legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), and any controlling Person of
any such underwriter, against any Damages (defined below), in each case only to the extent that such Damages arise out of or are
based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of the
Holder expressly for use in connection with such registration; and the Holder will pay to the Company and each other aforementioned
Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding
from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained
in this Subsection 9(f) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement
is effected without the consent of the Holder, which consent shall not be unreasonably withheld. For purposes of this Section 9,
“Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject
under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim or liability (or
any action in respect thereof) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material
fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required
to be stated therein, or necessary to make the statements therein not misleading; or (iii) any violation or alleged violation by
the indemnifying party (or
any of its agents or affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or
regulation promulgated under the Securities Act, the Exchange Act, or any state securities law.

 

    	2

    	 

    

 

(ii) Promptly after
receipt by an indemnified party under this Subsection 9(f) of notice of the commencement of any action (including
any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim
in respect thereof is to be made against any indemnifying party under this Subsection 9(f),
give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such
action and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified
party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified
party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between
such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying
party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to
the indemnified party under this Subsection 9(f), to the extent that such
failure materially prejudices the indemnifying party’s ability to defend such action. The failure to give notice to the indemnifying
party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Subsection 9(f).

 

(iii) Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

 

(iv) Unless otherwise
superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations of the
Company and the Holder under this Subsection 9(f) shall survive the completion of any offering of Registrable Securities
in a registration under this Section 9, and otherwise shall survive the termination of this Warrant.

 

(g)          Termination
of Registration Rights. The right of the Holder to request registration or inclusion of Registrable
Securities in any registration pursuant to Subsection 9(a) shall terminate upon such time as Rule 144 or another similar exemption
under the Securities Act is available for the sale of all of the Holder’s shares without limitation during a three-month
period without registration. 

 

10.         Charges,
Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or
transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall
be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by a form of assignment acceptable
to the Company duly executed by the Holder; and the Company may require, as a condition thereto, the payment of a sum sufficient
to reimburse it for any transfer tax incidental thereto.

 

11.         Investment
Representations. By accepting this Warrant, Holder represents and warrants to the Company that: (i) this Warrant is being acquired
by it for its own account for investment purposes only and (subject to the disposition of its property being at all times within
its control) not with a view to resale, distribution, or other disposition; (ii) any Warrant Shares which may be issued to Holder
upon exercise of this Warrant will be acquired by it for its own account for investment purposes only and (subject to the disposition
of its property being at all times within its control) not with a view to resale, distribution, or other disposition; (iii) Holder
is able to bear the economic risk of investment in this Warrant and the Warrant Shares, can afford to sustain a total loss on such
investment, and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits
and risks of its proposed investment; (iv) when issued, and upon any exercise of the Warrant, Holder acknowledges that it is and
will be an “accredited investor” as such term is defined in Rule 501(a)(1), (2), (3), (7) or (8) under the Securities
Act; (v) Holder understands that there is no public market for this Warrant, that there may never be a public market for this Warrant,
that in the future there may not be a public or liquid market for the Warrant Shares, and, therefore, that Holder may have to bear
the risk of its investment in this Warrant and any Warrant Shares indefinitely; and (vi) subject to Section 5.2 hereof, the Company
shall not be required to issue any of the Warrant Shares unless such issuance complies with the Securities Act and any applicable
state or other securities laws. Holder understands and acknowledges that the Company is relying upon the accuracy and truthfulness
of these representations and warranties to issue the Warrant and any Warrant Shares to Holder.

 

12.         Loss,
Theft, Destruction or Mutilation. Upon receipt by the Company of evidence reasonably satisfactory to it that this Warrant has
been mutilated, destroyed, lost or stolen, and in the case of any destroyed, lost or stolen Warrant, a bond of indemnity reasonably
satisfactory to the Company, or in the case of a mutilated Warrant, upon surrender and cancellation thereof, the Company will execute
and deliver in the Holder’s name, in exchange and substitution for the Warrant so mutilated, destroyed, lost or stolen, a
new Warrant of like tenor substantially in the form thereof with appropriate insertions and variations.

 

13.         No
Stockholder Rights. The Holder shall not by virtue hereof be entitled to any rights as a stockholder in the Company.

 

14.         Definition
of Person. For purposes of this Warrant, “Person” means an individual, corporation, partnership, limited
liability company, trust or other entity.

 

15.         Headings.
The descriptive headings of the several sections of this Warrant are inserted for convenience only and do not constitute a part
of this Warrant.

 

16.         Governing
Law. This Warrant shall be governed by the substantive laws of the State of Delaware, without regard to principles of conflicts
of law.

 

17.         Amendment.
This Warrant may be amended, waived or terminated only by an instrument in writing signed by the Company and the Holder.

 

18.         Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant

 

19.         Acceptance.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to the foregoing terms and conditions.

 

IN WITNESS WHEREOF, the Company has
caused this Warrant to be signed by its duly authorized officer on the date of this Warrant.

 

	 	BLONDER TONGUE LABORATORIES, INC.

 

	 	By:	\s\ James A. Luksch	 
	 	 	James A. Luksch
	 	 	Chief Executive Officer

 

    	3

    	 

    

 

RIDER A

 

TO

 

WARRANT TO PURCHASE 100,000 SHARES OF
COMMON STOCK

OF

BLONDER TONGUE LABORATORIES, INC.

 

PURCHASE AGREEMENT

 

	 	Date:	 	 

 

TO:

 

The undersigned, pursuant to the provisions
set forth in the attached Warrant, hereby agrees to purchase _____________ shares of Common Stock covered by such Warrant, and
makes payment herewith in full therefor at the price per share provided by this Warrant.

 

	 	ADAPTIVE MICRO-WARE, INC.
	 	 
	 	By:	 	 
	 	Name:
	 	Title:

 

    	4Exhibit 10.68

 

THE PAYMENT OF PRINCIPAL AND INTEREST ON
THIS NOTE IS SUBJECT TO CERTAIN SUBORDINATION PROVISIONS SET FORTH IN SECTION 11 HEREOF. THIS NOTE HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY COMPARABLE STATE SECURITIES LAW.

 

PROMISSORY NOTE

 

	$__________	November __, 2012
	 	Fairport Harbor, Ohio

 

FOR VALUE RECEIVED,
the undersigned OurPet’s Company
(the “Maker”), having a principal address of 1300 East Street, Fairport Harbor, Ohio, 44077, hereby promises
to pay to the order of __________________ (the “Holder”), the
principal amount outstanding to Holder up to One Hundred Thousand and 00/100 Dollars ($100,000.00), together with interest at the
prime rate as printed in the Wall Street Journal for such business day (“Prime”),
plus three percent (3%) per annum, compounding quarterly, and payable as set forth below:

 

1.             This Promissory Note (the “Note”)
was issued in connection with the execution a loan made pursuant to a certain Subscription Agreement dated _________, 2012 (the
“Subscription Agreement”), by and among the Maker, the Holder and other named parties thereto (the “Other
Loan Parties”).

 

2            
 Payment of the outstanding principal balance and all outstanding accrued interest shall be made no later than
thirty-six (36) months from the date of this Note as set forth above; provided, however, the outstanding principal balance
and all outstanding accrued interest may be subject to conversion into certain other securities pursuant to the terms and
conditions set forth in the Contribution Agreement.

 

3.             All payments on or in respect
of this Note shall be made by check (unless otherwise agreed by the Maker) to the Holder at 1801 East Ninth St., Suite 1700, Cleveland,
Ohio 44114 or, at the option of the Holder, at such other place and time as the Holder may, at any time or from time to time, designate
to the Maker in writing.

 

4.             The Maker may, at any time or
from time to time, prepay all or any part of the amounts due hereunder without any premium or penalty; provided, however, that
the Maker shall not make any such prepayment hereunder without prepaying, on a pari passu basis, amounts due under
each note outstanding to the Other Loan Parties issued pursuant to the Contribution Agreement.

 

5.             Absent an express waiver by the
Holder or any agreement to modify the due date, if Maker fails to pay any amount required to be paid pursuant to this Note when
it becomes due and payable, and such default continues for a period of fifteen (15) business days after Maker’s receives
notice of such default, then any remaining unpaid principal shall be subject to the interest rate of Prime plus five percent (5%)
per annum from the due date until the amounts due hereunder are paid in full.

 

    	 

    	 

    

 

6.             If the Company becomes insolvent,
and such insolvency leads to the appointment, whether voluntary or involuntary, of a receiver or trustee for any property of the
Company, then the payment obligations owed under this Note, to the extent not already paid, shall automatically become due and
payable.

 

7.             Any demand or notice hereunder
may be made by delivering the same to the address set forth in the first paragraph of this Note, or by mailing the same by regular
U.S. mail, postage prepaid, to said address, with the same effect as if delivered in person.

 

8.             In the event
this Note is placed in the hands of an attorney for collection, or suit is brought on the same, then the Maker agrees to pay all
attorneys’ fees and collection costs, including all out-of-pocket expenses, incurred by the Holder.

 

9.             No extension of time for payment
of all or part of the amount owed under this Note at any time shall affect the liability of the Maker. The failure of the Holder
to exercise any of its rights hereunder shall not constitute a waiver of the same or of any other right in that or any subsequent
instance.

 

10.           Notwithstanding
anything in this Note or under any other agreement to the contrary, the obligations of Maker in respect of this Note will be subordinate
and junior in right of payment to any and all existing and future superior indebtedness, including, without limitation, all of
Maker’s existing and future indebtedness to First Merit Bank, N.A. (or any successor lender) provided that such future superior
indebtedness shall be limited to conventional bank and working capital financing (the “Superior Indebtedness”);
provided that regularly scheduled payments of principal and interest hereunder shall be permitted by Maker’s lenders at all
times other than during the continuation of a payment default under the Superior Indebtedness. Any delay in any payment under this
Note resulting from the restrictions set forth in this Section shall not result in a default hereunder, and Holder agrees not to
seek any remedies against Maker or otherwise with respect to Maker’s failure to pay to the extent such failure to pay is
as a result of such restrictions.

 

11.           No modification
or amendment of this Note shall be valid unless made in writing and signed by the parties hereto. The failure of Holder to exercise
any of its rights hereunder shall constitute a waiver of the same and of any other right in that or any subsequent instance. No
extension of time for payment of all or part of the amount owed under this Note at any time shall affect the liability of the Maker.

 

12.           The provisions
hereof shall inure to the benefit of, and shall be binding upon, the Holder, the Maker and their respective representatives, administrators,
successors and assigns.

 

IN WITNESS WHEREOF,
the Maker has executed and delivered this Note on the date first set forth above.

 

	 	OURPET’S COMPANY
	 	 
	 	By:	 
	 	Scott R. Mendes, Chief Financial Officer

 

    	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]